Comments
Loading...
CG Oncology (NASDAQ:CGON) Stock, Earnings Estimates, EPS, And Revenue
CG Oncology reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 18
EPS Estimate
$-0.390
Quarterly Revenue Estimate
$51.53K
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$684.00K
Analyze the earnings history of CG Oncology using advanced sorting and filters.
Data brought to you by Benzinga APIs
CG Oncology (CGON) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-12 | $-0.30 | $-0.36 | 16.7 % |
| Q2 | 2024-08-08 | $-0.28 | $-0.37 | 24.3 % |
| Q1 | 2024-05-09 | $-0.36 | $-0.31 | -16.1 % |
CG Oncology (CGON) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-12 | $0 | $100.00K | -100.0 % |
FAQ
When is CG Oncology (NASDAQ:CGON) reporting earnings?
CG Oncology (CGON) is scheduled to report earnings on February 18, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
What were the latest earnings per share (EPS) for CG Oncology (NASDAQ:CGON)?
The Actual EPS was $-0.30, which beat the estimate of $-0.36.
What were CG Oncology’s (NASDAQ:CGON) revenues?
The Actual Revenue was $0K, which missed the estimate of $100K.
Browse earnings estimates, EPS, and revenue on all stocks.